EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Paraneoplastic Motor Neuropathy in Nodular Sclerosis Hodgkin’s Lymphoma: Case Report

Jayesh Menon iD, Tyler Rehbein iD, Patrick Reagan, Carla Casulo iD

Case Reports in Hematology · 2026-01 · 2026 (1)

DOI: 10.1155/crh/9468544 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Hematology, online erschienen am 30.04.2026. Verfasst von Jayesh Menon und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester School of Medicine, Rochester, New York, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraneoplastic neurological syndromes (PNS) are an uncommon complication of malignancy, characterized by autoantibody generation against neuronal structures, causing a spectrum of neurological syndromes affecting the central, peripheral, and/or autonomic nervous systems. PNS in lymphoma is exceedingly rare and there is limited evidence on the features, incidence, and severity of these neurological sequelae secondary to malignancy. Here, we report on a case of isolated diffuse motor neuropathy secondary to underlying nodular‐sclerosis classical Hodgkin’s lymphoma (cHL) in a 71‐year‐old male. This patient initially presented to the hospital with 3 months of progressive generalized weakness, weight loss, gait instability, and a rash. A broad workup revealed evidence of diffuse lymphadenopathy, which was characterized as nodular‐sclerosis cHL on biopsy. Concurrent neurological workup demonstrated generalized axonal motor neuropathy on nerve conduction studies with negative serologies for a panel of paraneoplastic autoantibodies, but positive Asialo‐GM1 titers, a marker of autoimmune neuropathy. The patient was initiated on doxorubicin, vinblastine, and dacarbazine (AVD) for their lymphoma and received two doses of IVIg for their motor neuropathy, which did not reoccur. The patient was transitioned to brentuximab + nivolumab for 4 cycles, followed by nivolumab + AVD for 6 cycles with a complete response and no evidence of disease. Asialo‐GM1‐associated isolated diffuse motor neuropathy in Hodgkin’s lymphoma has not been previously reported in the literature. In this case report, we review the 2021 updated diagnostic criteria for the diagnosis of paraneoplastic neurological syndromes in the context of this patient presentation to highlight an instance where these guidelines do not fully capture the wide spectrum of PNS.

Autor:innen und Institutionen

  • University of Rochester School of Medicine, Rochester, New York, USA.
  • Department of Neurology, University of Rochester, Rochester, New York, USA, rochester.edu.
  • Division of Hematology and Oncology, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA, rochester.edu.

ORCID-Profile: Jayesh Menon, Tyler Rehbein, Carla Casulo

Zitieren

APA

Menon, J., Rehbein, T., Reagan, P., & Casulo, C. (2026). Paraneoplastic Motor Neuropathy in Nodular Sclerosis Hodgkin’s Lymphoma: Case Report. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/9468544

Vancouver

Menon J, Rehbein T, Reagan P, Casulo C. Paraneoplastic Motor Neuropathy in Nodular Sclerosis Hodgkin’s Lymphoma: Case Report. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/9468544

BibTeX
@article{Menon2026,
  author = {Menon, Jayesh and Rehbein, Tyler and Reagan, Patrick and Casulo, Carla},
  title = {Paraneoplastic Motor Neuropathy in Nodular Sclerosis Hodgkin’s Lymphoma: Case Report},
  journal = {Case Reports in Hematology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crh/9468544}
}
Kostenlos starten →